Fundraising Fox

Deval Lashkari

Investor

Partner at Telegraph Hill Partners · Board director at Panome Bio · Board director at Community Bio · Board director at Nimble Therapeutics

San Francisco Bay Area

Writes $100K – $5M checks · typically $150K

About

Deval Lashkari is a Senior Partner at Telegraph Hill Partners. He has worked in life science venture capital and private equity, with expertise in diagnostics, business development, and entrepreneurship.

Contact· self-published, not guessed

Board director at Panome Bio

Intro paths

In turn, Deval can intro founders to Panome Bio's investors below.

Co-founders at Panome Bio

EWEdward Weinstein
Edward WeinsteinExecutive Officer, Director
TCTom Cohen
Tom CohenExecutive Officer

Board director at Community Bio

Intro paths

In turn, Deval can intro founders to Community Bio's investors below.

Board director at Nimble Therapeutics

Intro paths

In turn, Deval can intro founders to Nimble Therapeutics's investors below.

Experience

  1. Telegraph Hill PartnersSenior Partnercurrent2001 — presentSan Francisco Bay Area
  2. EditCo BioDirector Board of Directorscurrent2024 — present
  3. n6 TecDirector Board of Directorscurrent2023 — present
  4. Panome BioDirector Board of Directorscurrent2023 — present
  5. Mosaic BiosciencesBoardcurrent2022 — present
  6. ExcellosDirector Board Of Directorscurrent2021 — present
  7. Cell MicrosystemsDirector Board of Directorscurrent2021 — present
  8. Nimble TherapeuticsDirector Board Of Directorscurrent2019 — present
  9. Dynex Technologies, Inc.Director Board Of Directorscurrent2017 — present
  10. CarterraBoardcurrent2016 — present
  11. Agena BioscienceDirector Board Of Directors2014 — 2021Acquired by Mesa Labs
  12. Precision NanoSystems Inc.Director Board Of Directors2015 — 2021Acquired by Danaher
  13. AsuragenDirector Board Of Directors2017 — 2021Acquired by Bio-Techne
  14. Akoya Biosciences, Inc.Founding CEO, Director2015 — 2021NASDAQ: AKYA
  15. SAGE® LabsDirector Board Of Directors2013 — 2015Acquired by Horizon Discovery
  16. IncyteDirector of Product Development1997 — 1999
  17. SynteniDirector of Research & Product Development1996 — 1999Acquired by Incyte
  18. Operon BiotechnologiesStaff Scientist1988 — 1991

Skills & more

Private Equity8Venture Capital25Biotechnology16Venture Financing7Lifesciences11Mergers4Drug Discovery3Pharmaceutical Industry7Business Development7Start-ups9Strategy2Mergers & Acquisitions15
+10 moreCommercializationProduct DevelopmentLife SciencesMedical DevicesDue DiligenceCorporate DevelopmentTechnology TransferEntrepreneurshipCross-functional Team LeadershipBiopharmaceuticals

From Deval's professional profile.

Deals · 6

Community BioBoard seat

via Telegraph Hill Partners · filed Nov 2021 · $15M raise

Cell MicrosystemsBoard seat

via Telegraph Hill Partners · filed Nov 2021 · $12.7M raise

Precision NanoSystemsBoard seat

via Telegraph Hill Partners · filed Nov 2019 · $6M raise

Nimble TherapeuticsBoard seat

via Telegraph Hill Partners · filed Apr 2019 · $10M raise

Aquaro HistologyBoard seat

via Telegraph Hill Partners · filed Jun 2017 · $9.8M raise

Argonaut Manufacturing ServicesBoard seat

via Telegraph Hill Partners · filed Apr 2016 · $10.3M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

Panome Bio

Per SEC Form D filings.

Colleagues at Telegraph Hill Partners

Network6

Investors connected to Deval in public investor directories — a warm-intro map.

Frequently asked questions

Who is Deval Lashkari?
Deval Lashkari is a Senior Partner at Telegraph Hill Partners. He has worked in life science venture capital and private equity, with expertise in diagnostics, business development, and entrepreneurship.
Where does Deval Lashkari work?
Deval Lashkari is Partner at Telegraph Hill Partners and Board director at Panome Bio and Board director at Community Bio and Board director at Nimble Therapeutics.
What check size does Deval Lashkari write?
Deval Lashkari typically writes checks of $100K – $5M.
What boards does Deval Lashkari sit on?
Deval Lashkari holds tracked board seats at Aquaro Histology, Argonaut Manufacturing Services, Cell Microsystems, Community Bio, Nimble Therapeutics, Panome Bio, Precision NanoSystems.
Where did Deval Lashkari go to school?
Deval Lashkari studied at Stanford University School of Medicine (PhD, Genetics); University of California, Berkeley (Bachelor of Arts - BA, Genetics).

Same school

Shared employers